Devroe Eric 4
4 · Acrivon Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Devroe Eric
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2024-02-14$3.40/sh−723$2,458→ 59,710 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.